MEDULLOBLASTOMA RECURRENT

Clinical trials for MEDULLOBLASTOMA RECURRENT explained in plain language.

Never miss a new study

Get alerted when new MEDULLOBLASTOMA RECURRENT trials appear

Sign up with your email to follow new studies for MEDULLOBLASTOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Terminated 1

New drug tested in fight against recurrent childhood brain cancer

Disease control Terminated

This study tested an oral drug called CX-4945 in children and young adults whose medulloblastoma, a type of brain tumor, had come back after standard treatment. The main goals were to find the safest and most effective dose for younger children and to see if the drug could shrink…

Matched conditions: MEDULLOBLASTOMA RECURRENT

Phase: PHASE1, PHASE2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MEDULLOBLASTOMA RECURRENT

Get alerted when new MEDULLOBLASTOMA RECURRENT trials appear

New drug tested in fight against recurrent childhood brain cancer